Implantica AG reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 0.596 million compared to EUR 0.307 million a year ago. Net loss was EUR 3.36 million compared to EUR 4.55 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.85 SEK | +2.23% |
|
+2.75% | +24.90% |
08:00am | Implantica Announces Further Expansion of Refluxstop? Access in the Uk Nhs Public Hospital Network | CI |
05-15 | Transcript : Implantica AG, Q1 2024 Earnings Call, May 15, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.90% | 791M | |
+75.69% | 12.57B | |
+15.86% | 7.21B | |
-30.02% | 6.82B | |
+12.09% | 5.35B | |
+10.93% | 3.99B | |
-25.26% | 3.77B | |
-30.02% | 2.64B | |
+30.21% | 2.09B | |
-1.24% | 2.04B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2024